TEDA, China

Huiyan Mu

This inventor holds 1 USPTO granted patent. Top assignee: Asymchem Laboratories (Tianjin) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huiyan Mu. Retrieved from https://idiyas.com/inventor/huiyan-mu-89fagdy0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huiyan Mu - Innovator in Biochemistry

Introduction

Huiyan Mu is a notable inventor based in TEDA, China. She has made significant contributions to the field of biochemistry, particularly through her innovative work on transaminase mutants.

Latest Patents

Huiyan Mu holds a patent for a "Transaminase Mutant And Use Thereof." This invention showcases her expertise in enzyme engineering and its applications in various biochemical processes. She has 1 patent to her name, reflecting her commitment to advancing scientific knowledge.

Career Highlights

Huiyan Mu is currently employed at Asymchem Laboratories (Tianjin) Co., Ltd. This company is known for its focus on pharmaceutical development and manufacturing, providing a platform for Huiyan to apply her innovative ideas in a practical setting.

Collaborations

Huiyan has collaborated with talented coworkers, including Gage James and Yi Xiao. These partnerships have likely contributed to her success and the advancement of her research.

Conclusion

Huiyan Mu exemplifies the spirit of innovation in biochemistry through her patent and work at Asymchem Laboratories. Her contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…